System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor

An apparatus and method are provided for determining a patient's carbohydrate to insulin ratio (CIR) and insulin sensitivity factor (ISF), and using these values, along with values for current blood glucose level and deviation from target blood glucose level, for determining insulin dose in view of carbohydrate intake during a particular time period. The apparatus and method employ algorithms that can be implemented in any of a personal computer, personal data assistant, hand held computing device, blood glucose monitor, infusion pump, medication delivery pen, meter, calculator, among other therapeutic, diagnostic or informational devices used for managing a patient's blood glucose levels..

Medienart:

Patent

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Europäisches Patentamt - (2019) vom: 03. Apr. Zur Gesamtaufnahme - year:2019

Sprache:

Englisch

Beteiligte Personen:

GINSBERG BARRY H [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

615
A61B: Diagnosis; surgery; identification (analysing biological material g01n, e.g. g01n0033480000)
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
A61M: Devices for introducing media into, or onto, the body (introducing media into or onto the bodies of animals a61d0007000000; means for inserting tampons a61f0013260000; devices for administering food or medicines orally a61j; containers for collecting, storing or administering blood or medical fluids a61j0001050000); devices for transducing body media or for taking media from the body (surgery a61b; chemical aspects of surgical articles a61l; magnetotherapy using magnetic elements placed within the body a61n0002100000); devices for producing or ending sleep or stupor
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
Che
G01N: Investigating or analysing materials by determining their chemical or physical properties (measuring or testing processes other than immunoassay, involving enzymes or microorganisms c12m, c12q)
Med

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2019-04-03, Last update posted on www.tib.eu: 2022-09-07, Last updated: 2023-02-09

Patentnummer:

EP1571582

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA013489992